The U.S. Food and Drug Administration (FDA) today authorized a booster dose of the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11, without convening its vaccine advisory panel of independent experts to discuss Pfizer’s data on 5- to 11-year-olds — and based on a study subset of only 67 children, CNBC reported.
The U.S. Constitution gives vice presidents few official duties, but apparently, some of Vice President Kamala Harris’ aides are frustrated that she is often stuck in Washington, D.C., to carry out one of them.
"I've heard people say it's common sense (to get vaccinated), but what about all the other countries that have taken it and still put people in lockdown," says local Ghanaian.
The U.S. Food and Drug Administration on Tuesday authorized the use of a booster shot of Pfizer (PFE.N) and BioNTech's COVID-19 vaccine for children aged 5 to 11, making everyone in the country over the age of 5 eligible for a third shot.